Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III MenA/C conjugate vaccine in Chinese infants and toddlers
CTR20161020Phase 3Completed
- Sponsor
- CanSino Biologics Inc.
- Start
- Feb 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Menphecia in meningococcal meningitis, sponsored by CanSino Biologics Inc.. Started Feb 2017; status: completed.
02
Drugs
Menphecia
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on CTR20161020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20161020.